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Frequency of malignant transformation arising in giant con­
genital nevi is considered to be 4% - 5%. More than a half of 
the patients in which malignant melanoma developed in 
giant congenital nevi were under the age of to. It may be 
hypothesized that dermabrasion of giant congenital nevus 
may provoke malignant transformation. 
Some of the cell groups in giant congenital nevus are po­
tentially malignant. Some groups of nevus cells were larger in 
M alignant melanoma may arise de novo, as well as in association with preexisting pigmented lesions. These preexisting lesions include dysplastic nevi, common acquired nevi, and congenital nevi [1]. Although the association between malignant 
melanoma and giant congenital nevi is well known, a proper expla­
nation for the malignant transformation from giant congenital 
nevus has not been made. Possible related factors include a larger 
number of pigmented cells, certain potentially malignant nevus 
cells [2], and a deficiency of oxygen or an increase of CO2 in tissues. 
This paper deals with statistical studies of malignant transforma­
tion of giant congenital nevi, a case of malignant change in a giant 
congenital nevus, abnormal morphologic features of giant congeni­
tal nevus cells, and biologic differences between giant congenital 
nevus cells and malignant melanoma cells. 
Definition of Giant Nevus The definition of giant nevus varies 
from author to author. For example, Pers [3] defines a giant nevus as 
palm-sized on the face and twice palm size elsewhere; Greeley de­
fines it as a lesion that covers an area greater than 144 square inches 
[4]; Kaplan defines it as a lesion that "cannot be excised without 
significant deformity" [2]; and Kopf et al suggest an arbitrary size of 
20 cm or larger [5]. For the dermatomal distributions of nevi, 
"bathing trunk," "vest-like," "vest with collar," "garment," 
"cape-like," "coat-sleeve," "stocking-like," and so on are desig­
nated for giant congenital nevi (GCN) by several authors [6]. 
Clinical features of GCN include 1) grossly irregular surface, 2) 
increased pigmentation with varying shades of brown, and 3) hy­
pertrichosis [1]. 
Incidence of Malignant Transformation in Giant Congenital 
Nevi The frequency of giant congenital nevi progressing into 
malignant melanoma (MM) has been estimated from 2% to 42% in 
the US and Europe [2,7]. In Japan, three different groups estimated 
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size than those of other portions of nevus. Electron micro­
scopic observation revealed that nuclei of these larger nevus 
cells were significantly indented, and melanization of melan­
osomes was irregular. 
Coexistence of a-like actin with fi- and y-actins in giant 
congenital nevus cells and disappearance of a-like actin in 
malignant melanoma cells were noted. ] Invest Dermatol 
92:310S-314S, 1989 
the incidence of malignant melanoma arising in giant congenital 
nevi to be 3.2% to 5.6% (Table I) [8]. 
Age distribution of the incidence of malignant melanoma in giant 
congenital nevi is shown in Table II [2]. More than half of the 
patients in which malignant melanoma developed were under age 
ten. 
Lorentzen et al [9] estimated the lifetime risk of malignant de­
generation to be 4.6% in patients with giant congenital nevi, assum­
ing that the incidence was the same in all age groups from the data 
and life expectancy in Denmark (72.8 years of age in 1980). 
Rhodes et al [10], however, estimated the lifetime risk to be at 
least 6.3% because the risk is probably higher among the young, as 
described above, yielding an approximately 17 -fold risk for malig­
nant melanoma, compared with the general population. 
Surgical removal of giant congenital nevi could have lowered the 
percentage of malignant transformation. On the other hand, non­
radical treatment such as cryotherapy, partial excision, or dermabra­
sion may provide a malignant transformation [11]. Some patients 
with giant congenital nevi were treated and developed malignant 
melanoma after dermabrasion of nevi [12]. Oryu et al [12] reported a 
patient who received dermabrasion of giant congenital nevi twice, 
developed malignant melanoma 8 months after the second derma­
brasion, and died from malignant melanoma 4 months later. 
Histologic and ultrastructural studies of nonmalignant nodules in 
giant congenital nevi revealed that the nuclei of nevus cells were 
significantly indented, and these nevus cells contained abnormally 
melanized melanosomes. 
Case Report 
Case 1: A baby girl had a blue-black macule extending from the 
occipital region of her head down to the upper back since birth (Fig 
1). At the age of 2 months, dermabrasion of the upper back was 
performed. Three months after the dermabrasion, a subcutaneous 
nodule was evident in the treated area which was subsequently 
resected (Fig 2). Histologic observation demonstrated melanoma 
cells in the subcutaneous tissue (Figs 3 and 4). 
Case 2: A baby girl had garment-type giant congential nevi on the 
neck, back, hip, buttocks, and abdomen. Several soft black nodules 
were noted on the upper back (Fig 5). These soft nodules were 
resected, and the histology of these nodules was studied under light 
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Table I. Incidence of Malignant Melanoma Arising in 
Giant Congenital Nevi in Japan 
Authors 
1. Osmui T, Seiji M, 1983 [8] 
2. Ikeda S, Muzutani H, 1981 h 
3. Oohara K, 1987b 
TOTAL 
MM/GCN' 
4/87 
2/36 
1/31 
7/154 
, MM: malignant melanoma; GCN: giant congenital nevi. 
b Personal communications. 
Table II. Incidence of Malignant Melanoma in 
Giant Congenital Nevi: Age Distribution 
% 
4.6 
5.6 
3.2 
4.5 
Kaplan et aI, 1974 [2] Dermatosurgery Study Group in 
Japan, 1987' 
Age (year) 
At birth 
0-5 
6-10 
11-15 
16-20 
21-30 
31-
Total 
Number of Patients 
%:s 10 
� Personal communication. 
Number 
8 
15 
6 
4 
2 
4 
14 
53 
54.7% 
Age (year) 
0-4 
5-9 
10-24 
25-29 
30-
Total 
Number of Patients 
%:s 10 
Number 
6 
2 
o 
1 
3 
12 
66.7% 
and electron microscopes. Some groups of cells were larger in size 
than those of other portions of nevus (Figs 6 and 7). Electron micro­
scopic observation revealed that nuclei of these larger nevus cells 
were significantly indented (Fig 8), and melanization of melano­
somes was irregular (Fig 9). 
Figure 1. Clinical features of Case 1 at the age of 1 month. 
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Figure 2. Subcutaneous black nodule of case 1, 4 months after dermabra­
sion of nevus. 
Biological Differences Between Giant Congential Nevi and 
Malignant Melanoma Cells Actin is a major component of cyto­
skeletal proteins, and its alteration has been associated with malig­
nant transformation. So far, six isomers of actin have been identified 
in normal vertebrate cells [13,14]. By isoelectric focusing, these 
isomers can be classified into three species [a, p, and y). The a-act ins 
are the most acidic of the three species, and tissue-specific a-type 
isomers are found in skeletal and cardiac muscle and vascular 
smooth muscle cells. Ordinary non-muscle cells express only p and 
y actins, and another y-like actin is present in smooth muscle cells 
from chicken gizzard. In addition to these normal actins, point-mu­
tated p-actin [15 - 17] has been detected in a transformed human 
fibroblast cell line, the expression of which correlates with tumori­
genicity of the cells [18]. Another transformation-sensitive a-like 
actin was demonstrated in cultured chick embryo fibroblast [19], 
mouse NIH 3T3 cell line, and Rat-2 cells [20]. In B16 mouse mela­
noma cells, Taniguchi et al [21] detected a variant actin (AX) which 
decreases or disappears concomitantly with an increase in the meta­
static ability of the cells. They also reported that a-like actin, in 
addition to non-muscle p- and y-actins, was found in human benign 
pigment tissues but not in malignant melanomas [22]. 
Tissue from a 4-year-old girl with giant congenital nevi was 
minced, dissolved in O'Farrell's lysis buffer, and subjected to two­
dimensional polyacrylamide gel electrophoresis. 
On the gel stained with Coomassie blue, a spot (A') slightly more 
Figure 3. Histology of subcutaneous black nodule of case 1, HE stain 
(X300). 
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Figure 4. Higher magnification of Figure 3, Hl: ,talll (-"bOO). 
acidic than p and y actins was visualized. When the proteins were 
further analyzed by Western blot and immunostained, the third 
a-like spot reacted with anti-actin monoclonal antibody, as did 
authentic muscle actin, p, and y actins (Fig to). This finding indi­
cates that the third spot is an actin isomer. 
Tissue from a 39-year-old woman with nodular malignant mela­
noma and metastasis in the left femoral lymph nodes was analyzed. 
Two-dimensional electrophoresis and silver staining were per­
formed to examine the proteins extracted from the specimen. No 
spot adjacent to p and y actins was detected. Disappearance of a-like 
actin was confirmed by Western blot analysis (Fig 11). 
Figure 5. Several soft black tumors of Case 2. 
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Figure 6. Histology obtained from a soft black tumor of Case 2, HE stain 
(X200). 
Figure 7. Histology obtained from a flat portion of giant nevus of Case 2, 
HE stain (X200). 
Figure 8. Electron photomicrograph of a nevus cell obtained from a soft 
black nodule, uranyl acetate, and lead citrate stain (X6000). 
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Figure 9. Electron photomicrograph of irregularly melanized melano­
somes on nevus cells obtained from a soft black nodule, uranyl acetate, and 
lead citrate stain (X20,OOO). 
DISCUSSION 
The incidence of malignant transformation from giant congenital 
nevi has varied between 1.8% and 42% [2,3,7]. This difference in 
frequency by authors may be due to how the total ?umber �� giant 
congenital nevi were collected and also to the varying definition of 
"giant." It is not easy to count the exact �umber of giant congen�tal 
nevi and also the exact number of the patients with giant congemtal 
nevi who developed malignant melanoma. 
Lorentzen et al [9] estimated the lifetime risk of malignant de­
generation to be 4.6% in patients with giant congenital nevi, assum­
ing the yearly rate of malignant change to be constant. Rhodes e
.
t al 
[10], however, estimated the lifetime risk to be at least 6.3%, taking 
into consideration that the risk is probably higher among the young. 
Although malignant transformation in giant congenital nevi may 
develop at any age, nearly 60% of these malignant melanomas de­
veloped during the first decade of life, as shown in Table II [2]. 
Three different groups inJapan estimated the incidence of malig­
nant melanoma arising in giant congenital nevi to be 3.2% to 5.6% 
[8]. Therefore, the frequency of ma�ignant transformation fro� 
giant congenital nevi is about 5%, which seems reasonable and IS In 
the same range as estimated for transformation in whites. 
rabbit skeletal muscle act1n 
Figure 10. a-like, p and r actins were detected in tissue from a 4-year-old 
girl with giant congenital nevus by Western blot analYSIS and Immunostam. 
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Figure 1 1. Only p and r actins were detected in tissue from a 39-year-old 
woman with nodular malignant melanoma and metastasIs 10 lymph nodes. 
Surgical elimination of giant congenital nevi could have lowered 
the percentage of malignant transformation. On the other hand, it 
may be hypothesized that non-radical treatment such as cryother­
apy, electrotherapy, partial excision, or abrasion may provoke a 
malignant transformation. One reported case in Japan developed 
malignant melanoma after two dermabrasions [12]. 
The complete and extensive resection of giant nevi in order to 
prevent the development of a malignant neoplasm is not practical 
because of the size of the nevus and the deep penetration of nevus 
cells, sometimes even into the underlying muscle [6]. 
Borges and Lineberger [23] suggest that malignant melanoma 
arising from giant congenital nevi might sometimes be relatively 
nonaggressive. In fact, in our case, one is still free of recurrent 
melanoma months after removal of the primary tumor. 
There is considerable controversy concerning the surgical treat­
ment of giant congenital nevi. The management of giant congenital 
nevi depends primarily on the size and the perceived risk or develop­
ment of malignancy. These lesions should be periodically docu­
mented, measured, and observed for alterations of their size, color, 
and topography [1]. 
A proper explanation for the malignant transformation from 
giant congenital nevi has not been established. Kaplan [2] postulated 
that 1) there could be a much greater number of melanocytes, and 2) 
there might be an increased malignant potential of certain histo­
logic types of nevus cells in giant congenital nevi [2]. We hypothe­
sized the possibility of a deficiency of oxygen or an increase of CO2 
in tissues of giant congenital nevi. 
Disappearance of a-like actin in tissues of malignant melanoma 
may be evidence that alteration of cytoskeletal proteins is one of the 
important processes in malignant transformation and/or progres­
sion, although functions and characterizations of the a-like actin 
which disappears in cells of malignant melanoma have yet to be 
investigated. Furthermore, these results suggest that analysis of 
actin may serve as an aid for diagnosis of benign and malignant 
pigment tissues. 
SUMMARY 
Frequency of malignant transformation arising in giant congenital 
nevi is about 5%. It may be hypothesized that dermabrasion of giant 
congenital nevus may provoke malignant transformation. S?me of 
the cell groups in giant congenital nevus are potentially malIgnant. 
Co-existence of a-like actin with P and y actins in giant congeni­
tal nevus cells and disappearance of a-like actin in malignant mela­
noma cells were noted in our study. 
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